CSIMarket
 


Acceleron Pharma inc  (XLRN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare


Acceleron Pharma Inc's Net Cash Flow Margin by quarter

Trends, Rankings, Statistics



XLRN Net Cash Flow Margin (Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
Y / Y Revenue Change 56.26 % 930.9 % 29.16 % 650.77 % -13.99 %
Y / Y Net Cash Flow Change - - - - -
Net Cash Flow Margin - - - 70.69 % -
Net Cash Flow Margin Total Ranking # 112 # 245 # # 352 #
Seq. Revenue Change -88.96 % 834.86 % -84.79 % 895.18 % -27.15 %
Seq. Net Cash Flow Change - - - - -


Commenting First Quarter 2020 Net Cash Flow Margin
Company's Net Cash Flow Margin improved in I. Quarter to 916.41 %, below company's average Net Cash Flow Margin.

Observing first quarter 2020 results within Biotechnology & Drugs industry 20 other companies have achieved higher Net Cash Flow Margin. While Net Cash Flow Margin total ranking has impoved so far to 112, from total ranking in previous quarter at 245.

XLRN's Net Cash Flow Margin first quarter 2020 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 21
Healthcare Sector # 63
Overall # 112

Net Cash Flow Margin Statistics
High Average Low
6908.86 % 1515.69 % 70.69 %
(Sep 30 2017)   (Jun 30 2019)



Financial Statements
Acceleron Pharma Inc's (Mar 31 2020) Net Cash Flow $ 40 XLRN's Income Statement
Acceleron Pharma Inc's (Mar 31 2019) Net Cash Flow $ 0 Quarterly XLRN's Growth
XLRN's Profits by Division See XLRN's Profits by Segment

Other Net Cash Flow Margin Profitability Ratios
XLRN's Cumulative Net Cash Flow Margin
Biotechnology & Drugs Industry Net Cash Flow Margin Trends and Statistics
Healthcare Sector Net Cash Flow Margin Statistics
Net Cash Flow Margin Profitability Trends for overall market
XLRN's Net Cash Flow Margin Profitability versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Margin
Lowest Ranking Net Cash Flow Margin
Net Cash Flow Margin Profit Margin for XLRN's Competitors
Net Cash Flow Margin Profit Margin for Acceleron Pharma Inc's Suppliers
Net Cash Flow Margin Profit Margin for XLRN's Customers

You may also want to know
XLRN's Annual Growth Rates XLRN's Profitability Ratios XLRN's Asset Turnover Ratio XLRN's Dividend Growth
XLRN's Roe XLRN's Valuation Ratios XLRN's Financial Strength Ratios XLRN's Net Cash Flow Growth
XLRN's Roa XLRN's Inventory Turnover Ratio XLRN's Growth Rates XLRN's Dividend Comparisons


Companies with similar Net Cash Flow Margin in the quarter ending Mar 31 2020, within Biotechnology & Drugs Industry Net Cash Flow MarginMar 31 2020 MRQ Net Cash FlowMar 31 2020 MRQ Revenue
Spero Therapeutics Inc   2,036.04 %$ 34.633 $ 1.701 
Infinity Pharmaceuticals Inc   1,921.73 %$ 8.225 $ 0.428 
Rapt Therapeutics Inc   1,512.94 %$ 14.146 $ 0.935 
Aclaris Therapeutics Inc   1,283.23 %$ 18.055 $ 1.407 
Pulse Biosciences Inc   1,237.18 %$ 0.965 $ 0.078 
Predictive Oncology Inc   985.08 %$ 2.905 $ 0.295 
Vir Biotechnology Inc   977.53 %$ 55.895 $ 5.718 
Acceleron Pharma inc  916.41 %$ 39.809 $ 4.344 
Protagonist Therapeutics Inc   746.07 %$ 27.209 $ 3.647 
Zymeworks Inc   738.11 %$ 61.034 $ 8.269 
Adma Biologics Inc   730.25 %$ 74.484 $ 10.200 
Aytu Bioscience Inc  698.92 %$ 57.005 $ 8.156 
Vaxart Inc   562.82 %$ 16.333 $ 2.902 
Cidara Therapeutics Inc   555.18 %$ 14.046 $ 2.530 
Arcus Biosciences Inc   536.51 %$ 9.389 $ 1.750 
Salarius Pharmaceuticals inc   521.53 %$ 5.908 $ 1.133 
Nanostring Technologies Inc   475.97 %$ 126.632 $ 26.605 
Voyager Therapeutics Inc   444.06 %$ 80.229 $ 18.067 
Celldex Therapeutics Inc   421.26 %$ 11.492 $ 2.728 
Atyr Pharma Inc  374.99 %$ 30.243 $ 8.065 
Catalyst Biosciences Inc   336.03 %$ 54.995 $ 16.366 
Heska Corp  333.45 %$ 102.215 $ 30.654 
Agenus Inc  201.45 %$ 30.476 $ 15.128 
Soligenix Inc   192.81 %$ 1.783 $ 0.925 
Intellia Therapeutics Inc   184.01 %$ 23.767 $ 12.916 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GRCK's Profile

Stock Price

GRCK's Financials

Business Description

Fundamentals

Charts & Quotes

GRCK's News

Suppliers

GRCK's Competitors

Customers & Markets

Economic Indicators

GRCK's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright Š 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071